128 related articles for article (PubMed ID: 28000151)
1. The Impact of Provider Networks on the Co-Prescriptions of Interacting Drugs: A Claims-Based Analysis.
Ong MS; Olson KL; Chadwick L; Liu C; Mandl KD
Drug Saf; 2017 Mar; 40(3):263-272. PubMed ID: 28000151
[TBL] [Abstract][Full Text] [Related]
2. Provider Patient-Sharing Networks and Multiple-Provider Prescribing of Benzodiazepines.
Ong MS; Olson KL; Cami A; Liu C; Tian F; Selvam N; Mandl KD
J Gen Intern Med; 2016 Feb; 31(2):164-171. PubMed ID: 26187583
[TBL] [Abstract][Full Text] [Related]
3. Co-Prescribing of Potentially Interacting Drugs during Warfarin Therapy - A Population-Based Register Study.
Rikala M; Hauta-Aho M; Helin-Salmivaara A; Lassila R; Korhonen MJ; Huupponen R
Basic Clin Pharmacol Toxicol; 2015 Aug; 117(2):126-32. PubMed ID: 25537751
[TBL] [Abstract][Full Text] [Related]
4. Detecting and Visualizing Outliers in Provider Profiling Using Funnel Plots and Mixed Effects Models-An Example from Prescription Claims Data.
Hirsch O; Donner-Banzhoff N; Schulz M; Erhart M
Int J Environ Res Public Health; 2018 Sep; 15(9):. PubMed ID: 30223551
[TBL] [Abstract][Full Text] [Related]
5. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
6. Provider collaboration: cohesion, constellations, and shared patients.
Mandl KD; Olson KL; Mines D; Liu C; Tian F
J Gen Intern Med; 2014 Nov; 29(11):1499-505. PubMed ID: 25060655
[TBL] [Abstract][Full Text] [Related]
7. [Impact of Geriatric Drug Guidelines on the Quality Requirement of Elderly Patients].
Fauvelle F; Kabirian F; Domingues A; Tubach F; Gault N; Abbas R
Therapie; 2015; 70(6):515-21. PubMed ID: 26242496
[TBL] [Abstract][Full Text] [Related]
8. Aligning clinical practice to PTSD treatment guidelines: medication prescribing by provider type.
Abrams TE; Lund BC; Bernardy NC; Friedman MJ
Psychiatr Serv; 2013 Feb; 64(2):142-8. PubMed ID: 23474508
[TBL] [Abstract][Full Text] [Related]
9. Improving antimicrobial prescribing in Irish primary care through electronic data collection and surveillance: a feasibility study.
Galvin S; Callan A; Cormican M; Duane S; Bennett K; Murphy AW; Vellinga A
BMC Fam Pract; 2015 Jul; 16():77. PubMed ID: 26135455
[TBL] [Abstract][Full Text] [Related]
10. Trends in naloxone prescriptions prescribed after implementation of a National Academic Detailing Service in the Veterans Health Administration: A preliminary analysis.
Bounthavong M; Harvey MA; Wells DL; Popish SJ; Himstreet J; Oliva EM; Kay CL; Lau MK; Randeria-Noor PP; Phillips AG; Christopher MLD
J Am Pharm Assoc (2003); 2017; 57(2S):S68-S72. PubMed ID: 28089521
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Opioid Prescribing Guidelines on Prescriptions by Emergency Physicians in Ohio.
Weiner SG; Baker O; Poon SJ; Rodgers AF; Garner C; Nelson LS; Schuur JD
Ann Emerg Med; 2017 Dec; 70(6):799-808.e1. PubMed ID: 28549620
[TBL] [Abstract][Full Text] [Related]
12. Potentially inappropriate prescribing and adverse drug reactions in the elderly: a population-based study.
Hedna K; Hakkarainen KM; Gyllensten H; Jönsson AK; Petzold M; Hägg S
Eur J Clin Pharmacol; 2015 Dec; 71(12):1525-33. PubMed ID: 26407684
[TBL] [Abstract][Full Text] [Related]
13. Early discontinuation: more frequent among general practitioners with high levels of prescribing.
Hansen DG; Gichangi A; Vach W; Felde LH; Larsen J
Eur J Clin Pharmacol; 2007 Sep; 63(9):861-5. PubMed ID: 17618428
[TBL] [Abstract][Full Text] [Related]
14. Prescribing in 2019: what are the safety concerns?
Coleman JJ
Expert Opin Drug Saf; 2019 Feb; 18(2):69-74. PubMed ID: 30657340
[TBL] [Abstract][Full Text] [Related]
15. Patient, Physician and Organizational Influences on Variation in Antipsychotic Prescribing Behavior.
Tang Y; Chang CC; Lave JR; Gellad WF; Huskamp HA; Donohue JM
J Ment Health Policy Econ; 2016 Mar; 19(1):45-59. PubMed ID: 27084793
[TBL] [Abstract][Full Text] [Related]
16. Frequency of ill-founded off-label prescribing in Dutch general practice.
Gijsen R; Jochemsen H; van Dijk L; Caspers P
Pharmacoepidemiol Drug Saf; 2009 Jan; 18(1):84-91. PubMed ID: 19111012
[TBL] [Abstract][Full Text] [Related]
17. Use of psychotropic drugs and analgesics among users of antiobesity drugs--a population based study.
Amundsen MO; Engdahl B; Berg C; Nordeng H
Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):273-9. PubMed ID: 20014050
[TBL] [Abstract][Full Text] [Related]
18. Comparing Shared Patient Networks Across Payers.
Trogdon JG; Weir WH; Shai S; Mucha PJ; Kuo TM; Meyer AM; Stitzenberg KB
J Gen Intern Med; 2019 Oct; 34(10):2014-2020. PubMed ID: 30945065
[TBL] [Abstract][Full Text] [Related]
19. Effect of a Rational Drug Use Policy on the prescribing safety in outpatient settings in Thailand.
Rattanachotphanit T; Waleekhachonloet O
Int J Pharm Pract; 2020 Dec; 28(6):608-616. PubMed ID: 32813302
[TBL] [Abstract][Full Text] [Related]
20. Changes in Provider Prescribing Patterns After Implementation of an Emergency Department Prescription Opioid Policy.
Osborn SR; Yu J; Williams B; Vasilyadis M; Blackmore CC
J Emerg Med; 2017 Apr; 52(4):538-546. PubMed ID: 28111065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
